| |
Neurobiomed's focus is in the fast growing
market for new drug delivery formulations,
especially for the treatment of neurological
disorders. According to Datamonitor, a
leading marketing research firm, the market
size of the global drug delivery market is
in excess of US$66 billion, and is estimated
to grow to US$114 billion by 2007.
Controlled release of therapeutic drug
formulation is important for better patient
safety and for improving drug
bioavailability. Over the past decade,
pharmaceutical and biotechnology companies
have established relationship with drug
delivery companies, to enhance the delivery
of new drugs while also extending the patent
protection of their current drugs.
NanoBio
Drug Delivery System™
Our
patented NanoBio Drug Delivery System™ is
based on the advanced development of the
novel nanostructure bio-electric membrane
for drug delivery and diagnostic
applications.
-
NanoBio Membrane 's™
properties make it an ideal drug
delivery platform, with
high
efficiency/capacity of drug loading-up
to 97%
-
safe biodegradable product
-
Ensure
aseptic system with built-in nanoscale
membrane (50 nanometers) eliminating
particulates, bacteria, and endotoxin.
-
Heat and
radiation stable for ease of gamma
radiation
-
NanoBio
Membrane is suitable for most
injectable formulations
-
Nanoscale pore
size and Bio-electric charges can be
controlled to accommodate different
drug release pharmacokinetics (over
hours/days/weeks and months)
-
Bio-electric charges of the membrane
enable interface with
microelectronic processor for
precise programmable controlled
delivery
-
Self-regulating delivery system with
built-in microchip for ‘smart'
monitoring and diagnostic
applications.
For
further information, please contact our
Clinical Research Manager at research@neurobiomed.com
|